TAGS chemotherapy

Nausea and vomiting caused by chemotherapy are among the most frequent and worst tolerated side effects of anti-cancer treatments. The evidence of the prognostic significance of the dose intensity and dose dense led researchers to develop increasingly aggressive chemotherapy schemes with ever higher doses of drugs. Vomiting is disabling and, along with alopecia, is among the most poorly tolerated... read

Introduction The management of SCLC has been recently improved and survival rates are 15-25% at 2 years among patients with limited stage and 0-3% among those with extensive disease. The median overall survival with the combination chemotherapy is 14 to 16 months for patients with limited disease and 8 to 11 months for those with extensive disease. Most controlled clinical trials of SCLC define... read

Loss of fertility is one of the most frequent consequences for patients undergoing treatments with chemotherapy and/or radiation for cancer. When the disease occurs at young age, that is when the patient has not yet achieved his or her desire for maternity or paternity, the inability to have biological children may cause great sense of deprivation and frustration. Just recently the news... read

A few days ago, the FDA (Food and Drug Administration, the American institution that controls food and drug safety) approved the use of Ipilimumab, a drug based on a monoclonal antibody, which has yielded encouraging results in the fight against melanoma. During the testing phase of this antibody, the survival of patients has increased significantly: it has almost doubled at one year, rising... read